NeoChord recently announced positive results from a clinical study of its transcatheter NeXuS system for mitral chordal repair. The company's global early feasibility study treated patients with the transcatheter NeXuS system and results at one-year follow-up demonstrated notable clinical benefit and patient physiological improvement, according … [Read more...] about NeoChord announces positive study results from transcatheter mitral chordal repair device
NeoChord
NeoChord appoints executive chair to lead early feasibility study of transcatheter mitral chordal repair device
NeoChord appointed Dr. Martin Leon as executive chair of the company's U.S. early feasibility study of its Transcatheter Nexus system. Leon will be responsible for overseeing and leading the company's initiatives to advance its U.S. regulatory strategy for the Nexus system. He will also guide the company's overall global regulatory strategy as … [Read more...] about NeoChord appoints executive chair to lead early feasibility study of transcatheter mitral chordal repair device
